Good Morning America: Dr. Kristi Funk Announces Cynvenio's New Clinical Research Study

By ABC News • March 3, 2016

Dr. Kristi Funk discusses Cynvenio's new clinical research study for women with triple negative breast cancer (TNBC).

Dr. Kristi Funk discusses Cynvenio's new clinical research study for women with triple negative breast cancer (TNBC).

"It is important to raise awareness about this particular type of breast cancer because, compared to other cancers, triple negatives are aggressive," Funk said.  "As a group, triple negatives cause the highest recurrence rates and lowest survival rates of all the breast cancer subtypes."

...However, there may be great news on the horizon. Funk is involved in new research that she says will hopefully make detecting recurrences faster and easier. The clinical trial starts today.

Read the full article and watch the interview on ABC News →